Radical Liberals Rewrite ‘Motherhood’ Again

Voters at polling booths in a gymnasium
Photo: Steve Sanchez Photos / Shutterstock

When regulators change the words that anchor clinical rules, they change who sees themselves in the system and how programs are administered; Pennsylvania’s proposed shift from “pregnant woman/mother” to “pregnant/postpartum individual” is precisely that kind of consequential, if prosaic, rewrite—aimed at making eligibility rules, surveillance requirements, and program guidance cover everyone who is clinically pregnant or postpartum while keeping the substance of care intact.

The Short Version

  • Pennsylvania’s health department proposed replacing sex-specific terms (for example, “pregnant woman,” “mother of a newborn”) with gender-neutral terms (“pregnant individual,” “postpartum individual”) across a multi-hundred-page regulatory package.
  • The revisions target administrative and clinical provisions—like infectious-disease testing and postpartum eligibility—without changing the underlying clinical duties or benefits.
  • Critics argue the wording “erases women” and subordinates biology to ideology; their challenge is philosophical, not a factual refutation of what the text does.
  • The move aligns with a broader health-communications trend toward inclusive phrasing, though woman-centric terminology still overwhelmingly dominates medical literature.

What the proposal actually changes: language, not coverage or clinical standards

The heart of the package is definitional. Reported summaries of the Pennsylvania Department of Health’s proposal describe a comprehensive terminology swap across roughly 500 pages—replacing “pregnant woman” and “mother of a newborn” with “pregnant individual” and “postpartum individual”—including in provisions that set testing expectations during pregnancy and postpartum care touchpoints. As presented, these edits do not relax public-health obligations (for example, screening rules) and do not retract benefits; they recast the referent population in language that captures all who can be clinically pregnant and postpartum, including a small number of transgender and nonbinary patients. The policy mechanics remain: eligibility, required screenings, and timetables survive the wording change.

That administrative continuity matters. Pennsylvania has separately updated postpartum coverage windows in Medicaid and CHIP to 12 months—moves documented in federal plan filings—which demonstrate the direction of travel on benefits is expansion, not contraction. Likewise, legislative action on postpartum observation benefits and existing state rules on pregnant patients in treatment programs continue to speak the language of obligations to the patient population; the neutralization of terms in the health code sits alongside, not in place of, those obligations.

Why inclusive wording shows up in law and guidance

Public-health language serves two masters: clinical precision and program inclusion. “Pregnant individual” is not a metaphysical claim; it is an administrative category designed to capture everyone in a clinical state that triggers specific duties—testing, counseling, coverage. Over the past decade, style guidance in perinatal care and public-facing clinical communication has encouraged either gender-neutral or gender-additive phrasing (“pregnant people” or “pregnant women and pregnant people”) to encompass all patients while retaining clarity about sex-linked physiology when relevant. Canadian vaccine guidance and several academic reviews advocate exactly this approach: use neutral terms when discussing populations and retain sexed language when a biological distinction is material to safety or efficacy.

Crucially, inclusive language has not crowded out woman-centered phrasing in research; it remains rare. A review of 500 pregnancy-related health articles found that only 1.2% used gender-inclusive terminology; the remaining 98.8% were woman-centric, with epidemiology showing zero adoption in the sample. This empirical baseline undermines the idea that regulators are erasing women from the health discourse writ large; the modal usage in science and medicine still centers women, with policy writers increasingly adopting broader terms where program eligibility, not sex classification, is the operative constraint.

The critics’ case and how to weigh it

Opponents argue that substituting “pregnant individual” for “pregnant woman” signals the triumph of ideology over biology and risks obscuring the sex-specific realities of obstetrics. Pennsylvania Family Council’s chief counsel framed the proposal as erasing a stable female category; a state lawmaker similarly accused the department of “erasing” words like woman and mother. These are sincerely held concerns about language and social meaning, but they do not present documentary contradictions to what the draft regulations reportedly do. The question is not whether pregnancy is sex-specific—it is—but whether administrative text should name a sex class or a clinical state when defining who is covered by a rule.

There is a legitimate caution here: “desexing” language in contexts where biological sex is clinically determinative can confuse readers and, at the margins, obscure risks that track with female anatomy. Commentators in medical journals have warned that indiscriminate neutralization can reduce women’s visibility in research or public guidance and recommend a context-sensitive compromise—use sexed terms when discussing sex-dependent risk, and use inclusive phrasing when the point is access or eligibility. Read this way, Pennsylvania’s move fits the latter bucket: programmatic definitions and universal screening obligations, not the pathophysiology of preeclampsia.

Mechanics: how wording interacts with screening, reporting, and benefits

Health codes do three operative things in perinatal care: they specify mandatory screenings and reporting (e.g., syphilis or other infectious-disease testing during pregnancy and postpartum), define eligibility for programs and time-limited benefits, and standardize facility and provider duties. A “pregnant individual” label functions as a catchment for those operational triggers; it neither changes who is clinically eligible for RPR testing nor alters the postpartum clock for coverage continuation. In parallel, Pennsylvania has been updating postpartum eligibility in Medicaid and CHIP to a full year, a shift recorded in state plan amendments; the semantics of “postpartum individual” harmonize with that policy frame and with federal terminology that often speaks of “postpartum coverage” without sexing the term.

Precision remains critical where sex matters. Research, informed consent, and risk communication should retain sex-specific clarity when discussing conditions whose incidence, presentation, or treatment varies with female reproductive biology. The better institutional practice—reflected in inclusive-language guidance from clinical and public-health sources—is additive rather than subtractive: use inclusive population labels for access, and be explicit about sex when biology is on point.

What this means going forward

If finalized, the Pennsylvania rewrite would place the state within a broader but still evolving consensus: administrative texts lean inclusive to make rules read as they apply, while clinical content names sex where it is clinically dispositive. Expect continued debate over symbolism—words carry social freight—but judge the policy by operational outcomes. Do screening rates improve? Do eligibility determinations get cleaner? Do research summaries and patient materials maintain sex-specific clarity when discussing risk? The literature suggests both inclusion and precision are achievable if institutions are disciplined about context.

Sources:

lifesitenews.com, glensidelocal.com, dailywire.com, law.cornell.edu, palegis.us, pa.gov, medicaid.gov, americanfaith.com, aclupa.org, law.nyu.edu, patch.com, cnn.com, cambridge.org